Addressing the challenge of developing and supporting the expected term used in the Black-Sholes Option Pricing Model to determine fair value of grants to PEOs and NEOs.
Just released! Read VRC’s latest Industry Update on the CPG Personal Care in the public company space for relevant market data, trends in EBITDA multiples, notable deals and more.
Public company filer disclosures must provide added color on the full scope of executive compensation packages, changes in fair value of equity awards issued principal and named executive officers.
The continued growth of goodwill raises the stakes for U.S. & international standards setters considering changes to the way companies account for the assets.
High-level visual summaries of leading economic and financial indicators in major economic markets.
As public companies enter the traditional fourth-quarter impairment testing period, two big question marks are hanging over the market…
Both public and private companies carrying minority equity stakes at cost under FASB ASC 321 may need to fair value them due to COVID-19.
The SEC is making it a priority to focus on impairments related to COVID-19.
Not every company uses the same method for valuation. Recently, VRC and one of its key partners shared insight into their valuation “secret sauce.”
In market downturns, can we anticipate the impact on control premiums? VRC analyzed the data.